Treatment of refractory crystal-associated arthritis. Rheum Dis Clin North Am 1995 Feb;21(1):151-61
Date
02/01/1995Pubmed ID
7732165Scopus ID
2-s2.0-0028861779 (requires institutional sign-in at Scopus site) 34 CitationsAbstract
Crystal-associated arthritis includes gout, calcium pyrophosphate deposition (CPPD) disease, and the basic calcium phosphate (BCP)-related syndromes. In this article, the authors discuss the use of drug combinations and steroids for refractory gout patients and recommend management strategies for gout in the organ transplant recipient. Difficult cases of CPPD disease can be treated with colchicine and intra-articular steroids. The BCP-associated syndromes are best managed with NSAIDs and intraarticular measures. Experimental therapies for all forms of crystal-related arthritis are also discussed.
Author List
Rosenthal AK, Ryan LMAuthor
Ann K. Rosenthal MD Associate Dean, Chief, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Acute DiseaseArthritis, Gouty
Chondrocalcinosis
Chronic Disease
Humans
Middle Aged
Organ Transplantation
Postoperative Complications